CTKB Novinky na Forexe
Cytek Biosciences Board Approves Share Repurchase Of Up To $50 Mln
Cell analysis solutions company Cytek Biosciences, Inc. (CTKB) announced Thursday that its Board of Directors has approved the repurchase of up to an aggregate of $50 million of its common stock, subject to compliance with applicable law.
RTTNews
|
Pred 154 dňami
Cytek Biosciences Names William McCombe To Succeed Patrik Jeanmonod As CFO; Reaffirms 2024 Outlook
Cytek Biosciences, Inc. (CTKB) announced Tuesday that William McCombe has been appointed chief financial officer of the company, effective immediately. McCombe brings experience as a public company CFO at both large scale, and smaller, high growth technology companies.
RTTNews
|
Pred 233 dňami
